Epinephrine Bitartrate
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
Grundinformationen
- CAS
51-42-3- Standard-SMILES
CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O- InChIKey
YLXIPWWIOISBDD-NDAAPVSOSA-N- Summenformel
- C9H13NO3.C4H6O6
- Durchschnittliche Molmasse
- 333,29 g/mol
- Monoisotopische Masse
- 333,10598119
Überblick
Epinephrine Bitartrate is the bitartrate salt form of epinephrine, a direct-acting sympathomimetic amine with bronchodilator and vasoconstricting activity.
Namen und Bezeichner
- Bevorzugter Name
- Epinephrine Bitartrate
- IUPAC
- (2R,3R)-2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
Namen und Synonyme
Epinephrine bitartrate51-42-3Adrenaline bitartrateBronitinAdrenaline acid tartrateBronitin MistEPINEPHRINE TARTRATEEpinephrine d-bitartrateDTXSID3049415(-)-Epinephrine bitartrate(-)-Epinephrine (+)-bitartrateAdrenaline bitartate
Weitere Namen anzeigen
30Q7KI53AKAdrenaline (as tartrate)Epinephrine hydrogen tartrateL-epinephrine hydrogen tartrateDTXCID2029375Adrenalin tartrateNSC-756755Epinephrini hydrogenotartras
Datenbank-Bezeichner
- CAS
51-42-3- PubChem CID
- 5815
- DTXSID
DTXSID3049415- ChEMBL
CHEMBL1200818、CHEMBL1256958- ChEBI
CHEBI:228805- UNII
- 30Q7KI53AK
- EC Number
- 200-097-1
Eigenschaften
Berechnete StruktureigenschaftenWird ergänzt
- Polarare Oberfläche (TPSA)
- 188 Ų
- H-Brücken-Donoren
- 8
- H-Brücken-Akzeptoren
- 10
- Frei drehbare Bindungen
- 6
- Schwere Atome
- 23
- Formalladung
- 0
- Komplexität
- 288
Experimentelle und physikochemische Eigenschaften
Human Drugs
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Animal DrugsPharmaceuticals -> UK Veterinary Medicines Directorate List
Sicherheit und Regulatorisches
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
GHS-Klassifizierung
GHS Classification
Danger
H300 (99.1%): Fatal if swallowed [Danger Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 106 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Regulatory Information
Chemical: 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)-,[R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt)
Epinephrine bitartrate: HSNO Approval: HSR003812 Approved with controls
Other Safety InformationIMAP assessments - 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)-,[R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt): Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 1 (99.1%)
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Drugs that selectively bind to and activate alpha adrenergic receptors.
Drugs that selectively bind to and activate beta-adrenergic receptors.
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics.
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
Drugs used to cause constriction of the blood vessels.
Zugehörige Reaktionen
0
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Notizen zur Verbindung
Wird geladen…